In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Charcoal, activated Drug Master File in Korea (Charcoal, activated KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Charcoal, activated. The MFDS reviews the Charcoal, activated KDMF as part of the drug registration process and uses the information provided in the Charcoal, activated KDMF to evaluate the safety and efficacy of the drug.
After submitting a Charcoal, activated KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Charcoal, activated API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Charcoal, activated suppliers with KDMF on PharmaCompass.